首页> 外文期刊>Nephron >The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause Mortality
【24h】

The Preinterventional Cystatin-Creatinine-Ratio: A Prognostic Marker for Contrast Medium-Induced Acute Kidney Injury and Long-Term All-Cause Mortality

机译:介入治疗前胱抑素-肌酐的比率:中度急性肾损伤和长期全因死亡率对比的预后标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Contrast medium-induced acute kidney injury (CI-AKI) is an important iatrogenic complication following the injection of iodinated contrast media. The level of serum creatinine (SCr) is the currently accepted 'gold standard' to diagnose CI-AKI. Cystatin C (CyC) has been detected as a more sensitive marker for renal dysfunction. Both have their limitations. Methods: The role of the preinterventional CyC-SCr ratio for evaluating the riskfor CI-AKI and long-term all-cause mortality was retrospectively analyzed in the prospective single-center 'Dialysis-versus-Diuresis trial'. CI-AKI was defined and staged according to the Acute Kidney Injury Network classification. Results: Three hundred and seventy-three patients were included (average age 67.4 ± 10.2 years, 16.4% women, 29.2% with diabetes mellitus, mean baseline glomerular filtration rate 56.3 ± 20.2 ml/ min/1.73 m2 [as estimated by Chronic Kidney Disease Epidemiology Collaboration Serum Creatinine Cystatin C equation], 5.1% ejection fraction <35%). A total of 79 patients (21.2%) developed CI-AKI after elective heart catheteriza-tion, and 65 patients (17.4%) died during follow-up.
机译:背景/目的:造影剂诱发的急性肾脏损伤(CI-AKI)是注射碘化造影剂后的重要医源性并发症。血清肌酐(SCr)水平是目前公认的诊断CI-AKI的“黄金标准”。胱抑素C(CyC)已被检测为肾功能不全的更敏感标志物。两者都有其局限性。方法:在一项前瞻性单中心“透析与利尿研究”中,回顾性分析了干预前的CyC-SCr比在评估CI-AKI风险和长期全因死亡率中的作用。 CI-AKI是根据急性肾损伤网络分类定义和分级的。结果:纳入373例患者(平均年龄67.4±10.2岁,女性16.4%,糖尿病29.2%,平均肾小球滤过率56.3±20.2 ml / min / 1.73 m2 [根据慢性肾脏病估计流行病学协作血清肌酐胱抑素C方程],射血分数5.1%<35%)。择期心脏导管插入术后,共有79例患者(21.2%)发生CI-AKI,随访期间有65例患者(17.4%)死亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号